Immunovant, Inc. (IMVT)
NASDAQ: IMVT · IEX Real-Time Price · USD
28.61
-0.13 (-0.45%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Immunovant Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Immunovant stock have an average target of 44.67, with a low estimate of 4.00 and a high estimate of 57. The average target predicts an increase of 56.13% from the current stock price of 28.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Immunovant stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 8 | 9 | 9 | 9 | 10 | 10 |
Buy | 5 | 5 | 5 | 6 | 7 | 7 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 14 | 15 | 15 | 16 | 18 | 18 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +74.76% | Mar 28, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +67.77% | Mar 25, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +74.76% | Mar 13, 2024 |
JP Morgan | JP Morgan | Buy Initiates $51 | Buy | Initiates | $51 | +78.26% | Feb 20, 2024 |
Wolfe Research | Wolfe Research | Buy Initiates $55 | Buy | Initiates | $55 | +92.24% | Feb 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
14.77M
EPS This Year
-1.83
from -1.71
EPS Next Year
-1.92
from -1.83
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | n/a | 189.6M | 239.6M | 1.1B | 1.7B | 2.2B |
Avg | n/a | 14.8M | 65.1M | 406.6M | 747.4M | 1.2B |
Low | n/a | n/a | n/a | 27.9M | 102.2M | 369.4M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | - | 1,522.7% | 1,590.0% | 314.2% | 198.2% |
Avg | - | - | 340.8% | 524.7% | 83.8% | 58.4% |
Low | - | - | - | -57.1% | -74.9% | -50.6% |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | -1.74 | -0.87 | -1.05 | -0.12 | 2.30 | 4.64 |
Avg | -1.83 | -1.92 | -2.05 | -0.95 | 0.66 | 2.26 |
Low | -1.89 | -2.22 | -2.82 | -1.92 | -1.50 | -0.03 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | - | - | - | - | 602.2% |
Avg | - | - | - | - | - | 242.2% |
Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.